Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.57 |
| ▸ | CA2 | P00918 | 3/20 | 0.57 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA9 | Q16790 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | CTSD | P07339 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | STAT3 | P40763 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28558451 | 0.89 | RAB9A (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10606932 | 0.88 | ALDH1A1 (0.57) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13539020 | 0.86 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17391571 | 0.86 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1433789 | 0.86 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL31093097 | 0.86 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8363515 | 0.84 | CTSD (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2046808 | 0.84 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL22926249 | 0.84 | CA1 (0.56) | CA1CA2CA7CA9CA12 | |
| SCHEMBL16933973 | 0.84 | CA1 (0.50) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2019130-B1 | NOVEL COMPOUND, OPTICAL FILTER USING THE COMPOUND, AND OPTICAL RECORDING MATERIAL | ADEKA CORP (JP) | 2012-12-05 | — | — | EP | disclosed |
| US-7695793-B2 | Compound, optical filter and optical recording material using the same | ADEKA CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| US-20090137800-A1 | NOVEL COMPOUND, OPTICAL FILTER AND OPTICAL RECORDING MATERIAL USING THE SAME | ADEKA CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| EP-2019130-A1 | NOVEL COMPOUND, OPTICAL FILTER USING THE COMPOUND, AND OPTICAL RECORDING MATERIAL | Adeka Corporation (JP) | 2009-01-28 | — | — | EP | disclosed |
| EP-0403026-B1 | 12-Substituted-12H-dibenzo(D,G)(1,3)dioxocin-6-carboxylic acids, herbicidal compositions, and a method of controlling undesirable vegetation | DOWELANCO (US) | 1994-03-02 | — | — | EP | disclosed |
| US-5158597-A | Herbicidal 12-substituted 12H-dibenzo[d,g]dioxocin-6-carboxylic acids | THE DOW CHEMICAL COMPANY (US) | 1992-10-27 | — | — | US | disclosed |
| US-5071465-A | Preemergence; postemergence | THE DOW CHEMICAL COMPANY (US) | 1991-12-10 | — | — | US | disclosed |
| US-4999448-A | ALKYLATION WITH PHENYLTHIOMETHYL LITHIUM COMPOUND, CYCLIZATION, INTERMEDIATES FOR HERBICIDES | THE DOW CHEMICAL COMPANY (US) | 1991-03-12 | — | — | US | disclosed |
| EP-0403026-A1 | 12-Substituted-12H-dibenzo(D,G)(1,3)dioxocin-6-carboxylic acids, herbicidal compositions, and a method of controlling undesirable vegetation | DowElanco (US) | 1990-12-19 | — | — | EP | disclosed |
| US-4938790-A | Herbicidal 12-substituted 12H-dibenzo(D,G)(1,3)dioxocin-6-carboxylic acids | THE DOW CHEMICAL COMPANY (US) | 1990-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137800-A1 | NOVEL COMPOUND, OPTICAL FILTER AND OPTICAL RECORDING MATERIAL USING THE SAME | KCNQ2, KCNQ1, KCNQ4 | CA1 649/4885CA2 310/4885CA7 809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.